EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin

Bayazit Yunusbayev iD, Anna Bogdanova, Nadezhda Nadyrchenko, Lavrentii Danilov, Viktor Bogdanov, Grigory Sergeev, Radick Altinbaev, Fanil Bilalov, Milyausha Yunusbaeva

Microbiology Spectrum · 07.01.2025 · 13 (1)

DOI: 10.1128/spectrum.01382-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.01.2025. Verfasst von Bayazit Yunusbayev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Biomedicine, Saint-Petersburg State University, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Dysbiosis, Psoriasis, Gastrointestinal Microbiome, Feces. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Saint Petersburg State University, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many studies have reported gut microbiome alterations in psoriasis patients, suggesting dysbiosis. While evidence for dysbiosis and its link to pathogenesis remains inconclusive, murine models of psoriasis suggest that gut microbiome alterations develop in response to psoriasis-like inflammation. Hence, the dominant narrative about gut microbiome alterations’ impact on disease should be evaluated critically with more data and a well-powered approach. In this case-control study, we used deep sequencing of fecal samples from 53 psoriasis patients and 47 healthy donors to reconstruct the strain/species-level content of the gut microbiome. Unlike previous studies, we first identified matched pairs for each patient with healthy donors to adjust for microbiome variability and increase power. We found no evidence for depleted gut community diversity and apparent divergence in structure between patients and healthy individuals. However, our matched-pair approach identified a subtle but systematic increase in select bacteria among patients, e.g., Megasphaera elsdenii and Eubacterium CAG 180 . We next showed that these enriched species were correlated with elevated biomarkers of intestinal and systemic inflammation and liver function. Functionally, one of the top species, Megasphaera elsdenii , is a potent lactate utilizer in the context of intestinal lactic acidosis and inflammation. While our findings hardly support overt dysbiosis in the large intestine, the observed microbial changes correlate with moderately elevated calprotectin, albeit at levels not enough to diagnose ongoing inflammation. Hence, the sources of elevated inflammatory markers in patients’ intestines remain unclear and warrant further investigation to clarify their cause-and-effect relationship with the disease. IMPORTANCE With sufficient taxonomic resolution and sample size, this study critically evaluates new and published data on the gut microbiome in psoriasis patients. It shows that observed taxonomic changes in patients are modest and do not meet strict criteria for gut dysbiosis, at least in the large intestine. Instead, observed taxonomic changes in psoriasis patients can be explained by the microbial response to possible low-grade inflammation with unknown localization in the intestine and unclear impact on the host. The authors point out that published endoscopic data point to the small intestine as the site of gut inflammation. Therefore, further research focused on the small intestine would be informative to clarify the hypothetical gut-psoriasis link.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisPsoriasisGastrointestinal MicrobiomeFecesLeukocyte L1 Antigen ComplexBacteriaHumansCase-Control StudiesFemaleMaleMiddle AgedAdultBiomarkersYoung AdultAgedRNA, Ribosomal, 16S

Stichwörter der Autor:innen

dysbiosisgut microbiotalactatelow-grade Inflammationpsoriasis

Substanzen

Leukocyte L1 Antigen ComplexBiomarkersRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Institute of Translational Biomedicine, Saint-Petersburg State University, Saint-Petersburg, Russia.
  • Department of Genetics and Biotechnology, Saint-Petersburg State University, Saint-Petersburg, Russia.
  • SCAMT institute, ITMO University, Saint Petersburg, Russia.
  • Republican Dermatovenerologic Dispensary, Ufa, Russia.
  • Multiomics Laboratory, Moscow Institute of Physics and Technology, Moscow, Russia.
  • Medical Genetics Laboratory, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia.

ORCID-Profile: Bayazit Yunusbayev

Förderung

  • Russian Science Foundation
  • Saint Petersburg State University
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Yunusbayev, B., Bogdanova, A., Nadyrchenko, N., Danilov, L., Bogdanov, V., Sergeev, G., Altinbaev, R., Bilalov, F., & Yunusbaeva, M. (2025). Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin. Microbiology Spectrum, 13(1). https://doi.org/10.1128/spectrum.01382-24

Vancouver

Yunusbayev B, Bogdanova A, Nadyrchenko N, Danilov L, Bogdanov V, Sergeev G, et al. Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin. Microbiology Spectrum. 2025;13(1). doi:10.1128/spectrum.01382-24

BibTeX
@article{Yunusbayev2025,
  author = {Yunusbayev, Bayazit and Bogdanova, Anna and Nadyrchenko, Nadezhda and Danilov, Lavrentii and Bogdanov, Viktor and Sergeev, Grigory and Altinbaev, Radick and Bilalov, Fanil and Yunusbaeva, Milyausha},
  title = {Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {1},
  doi = {10.1128/spectrum.01382-24}
}
Kostenlos starten →